Gene · 6614
SIGLEC1: sialic acid binding Ig like lectin 1
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. SIGLEC1: sialic acid binding Ig like lectin 1. Genes, record 6614. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/6614
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q9BZZ2 | Sialoadhesin | 1,709 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents53
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4650780 A2 | 2025-11-19 | 6622 | Q9BZZ2 | Espacenet |
| EP 4640849 A2 | 2025-10-29 | 952 | Q9BZZ2 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 6368 | Q9BZZ2 | Espacenet |
| JP 2025138725 A | 2025-09-25 | 2254 | Q9BZZ2 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 3953 | Q9BZZ2 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 3953 | Q9BZZ2 | Espacenet |
| JP 2025519096 A | 2025-06-24 | 952 | Q9BZZ2 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 6368 | Q9BZZ2 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 6622 | Q9BZZ2 | Espacenet |
| WO 2025093745 A1 | 2025-05-08 | 288 | Q9BZZ2 | Espacenet |
1 to 10 of 53
See all 53 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants2,014
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | SIGLEC1 papers | Newest fiscal year |
|---|---|---|---|
| P51OD011092 | Support for National Primate Research Center | 12 | 2025 |
| P51OD011132 | Emory National Primate Research Center | 12 | 2025 |
| P51OD011104 | Tulane National Primate Research Center | 9 | 2025 |
| P30AI042853 | Providence/Boston Center for AIDS Research (CFAR) | 8 | 2025 |
| UL1TR001863 | Yale Clinical and Translational Science Award | 8 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 7 | 2025 |
| P30CA016359 | Cancer Center Support Grant | 7 | 2025 |
| UL1TR001866 | Developing, Demonstrating, and Disseminating Innovative Programs to Achieve Translational Success | 7 | 2025 |
| P30CA016087 | Cancer Center Support Grant | 6 | 2025 |
| P30CA013330 | Cancer Center Support Grant | 5 | 2025 |
1 to 10 of 2,014Source NIH's project files
See all 2,014 nih grantsPapers2,964
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Skin macrophage subsets in health and disease. | J Dermatol Sci | 2026 | 42816244 | PubTator, text mining | PubMed |
| Early monocyte subset signatures predict outcomes in unvaccinated COVID-19 patients. | Front Immunol | 2026 | 42812399 | PubTator, text mining | PubMed |
| Spatial Profiling and Prognostic Role of CD169+ Macrophages in Colorectal Cancer From Adjacent Nontumor Mucosa to Liver Metastasis. | J Immunol Res | 2026 | 42811675 | PubTator, text mining | PubMed |
| Mutations at Positions 181 and 185 Within the LCMV GP Protein Increase Tumor Cell Infectivity, Limit Induction of Type I Interferon, and Accelerate T Cell Activation. | Viruses | 2026 | 42797832 | PubTator, text mining | PubMed |
| Immune Profiling and Rapid Molecular Diagnostics in Severe Respiratory Infections and Sepsis: The Potential Clinical Perspective of CD169 and CD64. | Microorganisms | 2026 | 42795651 | PubTator, text mining | PubMed |
| Selective Whole-Blood Expression of Interferon-Stimulated Genes and TLR3/TLR7 in Type 1 Diabetes with Minimal Enterovirus-Targeted Amplification in Whole Blood. | Genes (Basel) | 2026 | 42792959 | PubTator, text mining | PubMed |
| A Novel Dominantly Segregating PSMB10 Splice-Site Variant in Familial Autoinflammatory Disease with Immunoproteasome and Interferon-Related Dysregulation. | Genes (Basel) | 2026 | 42792891 | PubTator, text mining | PubMed |
| CXCL2/CXCR2 pathway regulates CD169high large macrophages to promote progression of malignant pleural effusion from lung adenocarcinoma. | Front Med (Lausanne) | 2026 | 42780770 | PubTator, text mining | PubMed |
| Rethinking the Benign Nature of Class II Lupus Nephritis. | bioRxiv | 2026 | 42779877 | PubTator, text mining | PubMed |
| Single-cell profiling reveals context-dependent immune regulation shared by sepsis and systemic lupus erythematosus. | Front Immunol | 2026 | 42755868 | PubTator, text mining | PubMed |
1 to 10 of 2,964
See all 2,964 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/6614
GET https://conductscience.org/api/genes/v1/6614/patents?page=2